Ed Dybka, Vice-Chair

Ed Dybka is the General Manager at Ipsen Biopharmaceuticals Canada Inc..   In this role, he is responsible for overseeing all of Ipsen’s operations across all therapeutic areas in Canada  He is also a member of the Ipsen North America Leadership Team and the Ipsen Global Leadership Team.

Mr. Dybka has a wealth of experience and over 30 years in the pharmaceutical industry within the Canadian market. Prior to joining Ipsen, he led the development of an early stage biotech company as a joint venture between Mars Innovation (Toronto) and The Center for Drug Research and Development (Vancouver).  He was also the President & CEO of AstraZeneca Canada Inc., part of AstraZeneca PLC, one of the world’s leading biopharmaceutical companies. In 2012, Mr. Dybka led the Canadian establishment of Almirall, a start-up biopharmaceutical company focused on the treatment of respiratory diseases.    Earlier in his career Mr. Dybka held a number of executive roles at GlaxoSmithKline Canada including Vice President of Marketing, Sales and Public Affairs & Reimbursement.

In addition to his role at Ipsen, Mr. Dybka is currently Vice-Chair of the board of Life Sciences Ontario and a Director on the board of Clinical Trials Ontario.   He is also Vice-Chair of the Health & Biosciences Economic Strategy Table for the Federal Ministry of Health and Ministry of Innovation, Science and Economic Development which recently published a set of foundational recommendations to accelerate the growth of the Health & Biosciences sector in Canada.